For in vitro diagnostic use. Others Elecsys N-MID Osteocalcin IVD Elecsys® N-MID Osteocalcin CPS_000493 12149133122 N-MID Osteocalcin Elecsys cobas e 100 Elecsys N-MID Osteocalcin 04015630914296 Reagents, kits 100 tests cobas e 411/601/602 true 12149133160 N-MID Osteocalcin Elecsys cobas e 100 Elecsys N-MID Osteocalcin 04015630939084 Reagents, kits 100 tests cobas e 411/601/602 true 07027591190 N-MID Osteocalcin Elecsys E2G 100 Elecsys N-MID Osteocalcin 04015630940462 Reagents, kits 100 tests cobas e 402/801 true 12149133500 Elecsys N-MID Osteocalcin en 18 FF000000048B690E FF000000000C110E 12149133122 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of N‑MID osteocalcin in human serum and plasma. The determination is used for the control of antiresorptives therapeutic efficiency, e.g. for patients with osteoporosis or hypercalcemia.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 12149133501 Elecsys N-MID Osteocalcin en 7 FF0000000521590E FF000000000C7D0E 12149133160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of N-MID osteocalcin in human serum and plasma. The determination of osteocalcin, an indication of human bone formation and osteoblastic activity, may be useful as an aid in the management of postmenopausal osteoporosis.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07027591501 Elecsys N-MID Osteocalcin en 1 FF00000001DB3E0E FF00000001DB3E0E 07027591190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of N-MID osteocalcin in human serum and plasma. The determination of osteocalcin, an indication of human bone formation and osteoblastic activity, may be useful as an aid in the management of postmenopausal osteoporosis.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027591500 Elecsys N-MID Osteocalcin en 6 FF00000004A4FA0E FF000000047EAE0E 07027591190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of N‑MID osteocalcin in human serum and plasma. The determination is used for the control of antiresorptives therapeutic efficiency, e.g. for patients with osteoporosis or hypercalcemia.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en